1 – 10 of 84
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
- Refractory subacute steatohepatitis after biliopancreatic diversion
- 2016
- Monoclonal anti-envelope antibody AP33 protects humanized mice against a patient-derived hepatitis C virus challenge
- Hepatitis E virus in acute liver failure : an unusual suspect?
- Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1
- 2015
- Is hepatitis E virus an emerging problem in industrialized countries?
- 2014
- Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents
- The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice
- Significance of initial poor function after liver transplantation
- 2013
- Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models
- Safety and pharmacokinetics of single and multiple oral doses of MK-8742, an HCV NS5A inhibitor, in healthy subjects